Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

S100A4 mRNA expression level is a predictor of radioresistance of pancreatic cancer cells.

Kozono S, Ohuchida K, Ohtsuka T, Cui L, Eguchi D, Fujiwara K, Zhao M, Mizumoto K, Tanaka M.

Oncol Rep. 2013 Oct;30(4):1601-8. doi: 10.3892/or.2013.2636.

PMID:
23900547
2.

Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation.

Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Haraguchi N, Inoue H, Murayama S, Mori M.

Int J Oncol. 2006 Mar;28(3):705-13.

PMID:
16465376
3.

S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells.

Sekine H, Chen N, Sato K, Saiki Y, Yoshino Y, Umetsu Y, Jin G, Nagase H, Gu Z, Fukushige S, Sunamura M, Horii A.

Biochem Biophys Res Commun. 2012 Dec 14;429(3-4):214-9. doi: 10.1016/j.bbrc.2012.10.048.

PMID:
23085231
4.

MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells.

Wang P, Zhang J, Zhang L, Zhu Z, Fan J, Chen L, Zhuang L, Luo J, Chen H, Liu L, Chen Z, Meng Z.

Gastroenterology. 2013 Nov;145(5):1133-1143.e12. doi: 10.1053/j.gastro.2013.07.048.

PMID:
23916944
5.

Sonic hedgehog-Gli1 signaling pathway regulates the epithelial mesenchymal transition (EMT) by mediating a new target gene, S100A4, in pancreatic cancer cells.

Xu X, Su B, Xie C, Wei S, Zhou Y, Liu H, Dai W, Cheng P, Wang F, Xu X, Guo C.

PLoS One. 2014 Jul 29;9(7):e96441. doi: 10.1371/journal.pone.0096441.

6.

Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells.

Huang L, Xu Y, Cai G, Guan Z, Cai S.

Oncol Rep. 2012 Apr;27(4):917-22. doi: 10.3892/or.2011.1598.

7.

Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation.

Souchek JJ, Baine MJ, Lin C, Rachagani S, Gupta S, Kaur S, Lester K, Zheng D, Chen S, Smith L, Lazenby A, Johansson SL, Jain M, Batra SK.

Br J Cancer. 2014 Sep 9;111(6):1139-49. doi: 10.1038/bjc.2014.385.

8.

Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.

Mencía N, Selga E, Rico I, de Almagro MC, Villalobos X, Ramirez S, Adan J, Hernández JL, Noé V, Ciudad CJ.

BMC Cancer. 2010 Jun 1;10:250. doi: 10.1186/1471-2407-10-250.

9.

S100A4 siRNA inhibits human pancreatic cancer cell invasion in vitro.

Li N, Song MM, Chen XH, Liu LH, Li FS.

Biomed Environ Sci. 2012 Aug;25(4):465-70. doi: 10.3967/0895-3988.2012.04.012.

10.

RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells.

Tabata T, Tsukamoto N, Fooladi AA, Yamanaka S, Furukawa T, Ishida M, Sato D, Gu Z, Nagase H, Egawa S, Sunamura M, Horii A.

Biochem Biophys Res Commun. 2009 Dec 18;390(3):475-80. doi: 10.1016/j.bbrc.2009.09.096.

PMID:
19799859
11.

[Expression of S100A2 in secondarily radioresistant pancreatic cancer cells and significance thereof].

Wen Q, Zhao YP, Chen G, Zhang FQ, Zhang TP.

Zhonghua Yi Xue Za Zhi. 2006 Oct 31;86(40):2817-20. Chinese.

PMID:
17200013
12.

S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer.

Mahon PC, Baril P, Bhakta V, Chelala C, Caulee K, Harada T, Lemoine NR.

Cancer Res. 2007 Jul 15;67(14):6786-95.

13.
14.

S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma.

Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Fujita H, Nakata K, Ueda J, Sato N, Nagai E, Tanaka M.

J Gastrointest Surg. 2009 Oct;13(10):1852-8. doi: 10.1007/s11605-009-0978-4.

PMID:
19653048
15.

S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase.

Che P, Yang Y, Han X, Hu M, Sellers JC, Londono-Joshi AI, Cai GQ, Buchsbaum DJ, Christein JD, Tang Q, Chen D, Li Q, Grizzle WE, Lu YY, Ding Q.

Sci Rep. 2015 Feb 13;5:8453. doi: 10.1038/srep08453.

16.

S100A4 is frequently overexpressed in lung cancer cells and promotes cell growth and cell motility.

Chen N, Sato D, Saiki Y, Sunamura M, Fukushige S, Horii A.

Biochem Biophys Res Commun. 2014 May 9;447(3):459-64. doi: 10.1016/j.bbrc.2014.04.025.

PMID:
24732359
17.

High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.

Wang YY, Ye ZY, Zhao ZS, Tao HQ, Chu YQ.

Ann Surg Oncol. 2010 Jan;17(1):89-97. doi: 10.1245/s10434-009-0722-z.

PMID:
19820999
18.

Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.

Sack U, Walther W, Scudiero D, Selby M, Kobelt D, Lemm M, Fichtner I, Schlag PM, Shoemaker RH, Stein U.

J Natl Cancer Inst. 2011 Jul 6;103(13):1018-36. doi: 10.1093/jnci/djr190.

19.

Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin.

Chen M, Sinha M, Luxon BA, Bresnick AR, O'Connor KL.

J Biol Chem. 2009 Jan 16;284(3):1484-94. doi: 10.1074/jbc.M803997200.

20.

Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.

Rosty C, Ueki T, Argani P, Jansen M, Yeo CJ, Cameron JL, Hruban RH, Goggins M.

Am J Pathol. 2002 Jan;160(1):45-50.

Items per page

Supplemental Content

Support Center